WEDNESDAY, Sept. 9, 2020 — Researchers may have found a way for people with severe hemophilia to take their standard treatment less often, if the results of an early trial pan out. In what experts called a feat of bioengineering, scientists were able to create a “fusion protein” that may extend the interval between treatments… Read More: Early Trial Offers New Hope for People With Hemophilia »
The US Centers for Disease Control and Prevention warns that pandemics can be stressful and cause feelings of fear and anxiety. Couple the pandemic with being cooped up at home with family while working and kids home from school, and you may find yourself with a stress headache quite often. More than nine in 10… Read More: Got a stress headache? This 5-minute routine brings relief –… »
FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More: FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management… »
Researchers at George Washington University and Northwestern University have developed a new class of soft devices that can provide new functionality for catheters used in cardiac procedures. The new materials are soft electronics, including stretchable sensors and actuators, that when applied to the surface of a catheter system, could greatly assist in diagnosing and treating… Read More: Soft Electronics for Advanced Heart Catheters »